Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson’s disease-Reference-Cited by-同舟云学术

Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson’s disease

Published:2020-05-05 Issue:6 Volume:26 Page:2626-2632
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Kahana Meygal,Weizman Abraham^ORCID,Gabay Martin,Loboda Yelena,Segal-Gavish Hadar,Gavish Avishai,Barhum Yael,Offen Dani,Finberg John,Allon Nahum,Gavish Moshe

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

https://www.nature.com/articles/s41380-020-0742-4.pdf

Reference25 articles.

1. Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139:318–24.

2. Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A. Synthesis and release of dopamine in R Brain: comparison between substantia Nigra pars compacta, pars reticulata, and striatum. J Neurochem. 1989;52:1170–82.

3. Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R. Dopamine and levodopa prodrugs for the treatment of Parkinson’s Disease. Molecules. 2017;23:40.

4. Ninomiya H, Roch JM, Sundsmo MP, Otero DA, Saitoh T. Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth. J Cell Biol. 1993;121:879–86.

5. Mileusnic R, Lancashire C, Clark J, Rose SP. Protection against Abeta-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg. Behav Pharm. 2007;18:231–8.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An active & passive dual-targeting platform for the precise treatment, process monitoring and effective protection of central nervous system infection;Chemical Engineering Journal;2024-10

2. Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review;Drug Delivery and Translational Research;2024-04-08

3. A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus;Expert Opinion on Drug Delivery;2024-03-03

4. Clinical Insights into MicroRNAs in Depression: Bridging Molecular Discoveries and Therapeutic Potential;International Journal of Molecular Sciences;2024-03-01

5. Nanocarriers and Nano Drug Delivery Therapy in Neuro Diseases;Smart Nanomaterials Technology;2024